See also this year's filing and all EDGAR filings for this company.
PDF Report 0001328143_2020_Adamas_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001328143, Adamas Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 150,320,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,449,000 |
| 3 | remainder_Assets | 9,389,000 |
| 4 | LiabilitiesCurrent | 26,948,000 |
| 5 | LiabilitiesNoncurrent | 136,103,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 11,643,986 |
| 8 | SellingGeneralAndAdministrativeExpense | 121,368,177 |
| 9 | ResearchAndDevelopmentExpense | 28,834,735 |
| 10 | remainder_Expenses | 13,747,497 |
| 11 | remainder_Revenues | 49,692,881 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -95,801 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 162,158,000 |
| 1 | Liabilities | 163,051,000 |
| 2 | Expenses | 175,594,395 |
| 3 | Revenues | 49,692,881 |
| 4 | StockholdersEquity | -893,000 |
| 5 | NetIncome | -125,901,514 |
| 6 | ComprehensiveNetIncome | -125,949,414 |
| 7 | BaseVar | 275,296,038 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.787 |
| 9 | EconomicCapitalRatio | 1.34 |
Edgar->Model Mapping
Feature Distribution
Change over Time
